Gilead Sciences
Company · Pharmaceutical and Medicine Manufacturing · United States
American biopharmaceutical company
- Revenue
- $31.0B
- TTM to Sep 2026
- People
- 17,000
- Parts
- 4
- 6 sources
Updated
Daniel O'Day
Updated
Daniel O'Day is chief executive at Gilead Sciences, chair at Gilead Sciences.
01Roles
Each role as its source states it, with the dates when the source gives them.
- Gilead Sciences · Chief executiveMar 2019 to nowwikidata.org
- Gilead Sciences · Chair1 Mar 2019 to nowwikidata.org
02Their organizations
Open one for how it is built: its map, figures and connections.
03About this page
System Atlas lists notable people only in their roles at organizations, and only people with a Wikidata item. It never shows contact details, addresses, birth dates or family. Is this you, or do you act for them? Ask to be taken off and the team reviews it.
Ask to be taken off